Survival of Hemophagocytic Syndrome Secondary to Fungal and Bacterial Infection in a Pediatric Patient with HIV: A Case Report.
Erika Reina-BautistaOmar Esteban Valencia-LedezmaMaría Guadalupe Frías De LeónGustavo Acosta-AltamiranoCarlos Alberto Castro-FuentesPublished in: Pathogens (Basel, Switzerland) (2023)
HIV-associated hemophagocytic lymphohistiocytosis (HLH) is mainly due to infections caused by viruses, fungi, and, to a lesser extent, bacteria, often with fatal results. Case presentation: A 15-year-old pediatric patient from another institution was admitted to our hospital with a fever of unknown origin (FUO). Clinical analysis and laboratory studies diagnosed HIV infection. The approach to an FUO in a patient with AIDS is much more complex due to the search for common etiologies and opportunistic infections. In this case, disseminated histoplasmosis, pulmonary tuberculosis, pneumocystosis, and ehrlichiosis were diagnosed, prompting an urgent and comprehensive approach to prevent mortality. Due to the multiple infections, HLH was triggered. An early intervention with trimethoprim (TMP)-sulfamethoxazole (SMX), liposomal amphotericin B, doxycycline, and quadruple antiphimic therapy to suppress infections, in conjunction with the early administration of HLH treatment, favored the survival of this patient.
Keyphrases
- antiretroviral therapy
- case report
- pulmonary tuberculosis
- hiv infected
- human immunodeficiency virus
- hiv positive
- hiv testing
- hiv aids
- hepatitis c virus
- randomized controlled trial
- healthcare
- helicobacter pylori
- men who have sex with men
- type diabetes
- free survival
- stem cells
- emergency department
- acute care
- antibiotic resistance genes
- wastewater treatment
- smoking cessation
- electronic health record